FREDERICK, Md., Dec. 20 /PRNewswire-FirstCall/ -- BioElectronics Corporation, , announced today that Advent Medical Systems has signed a Distribution Agreement and placed their first order.
Advent Medical Systems, with offices at 444 Valley Drive, Syracuse, New York, will handle the distribution of ActiPatch to medical professionals in most of the counties in the state of New York. "We are delighted to have Advent Medical Systems join our growing distribution team. We are excited about this extraordinarily experienced group which will add to our growing national distribution," said Andrew Whelan, President of BioElectronics.
"This is one of the most exciting products that I have seen in the last five years. I am looking forward to working with BioElectronics in developing this market segment to improve patient outcome," said Tom Riddel, President of Advent Medical Systems.
For more information on Advent Medical Systems visit http://www.msadvent.com
ActiPatch(TM) is a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling.
For more information visit http://www.bioelectronicscorp.com
Safe Harbor Statement:
This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the companies have no control.
BioElectronics CorporationCONTACT: Andrew J. Whelan, President & CEO, or Lawrence H. Rosen, CFO,both of BioElectronics Corp., +1-301-644-3906, or fax, +1-301-644-3937, orinfo@bioelectronicscorp.com
